TCA
INSM icon

Transcend Capital Advisors’s Insmed INSM Stock Holding History

Transcend Capital Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,684
Closed -$314K – 631
2024
Q2 		$314K Buy
+4,684
New +$182K 0.02% 450

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Transcend Capital Advisors's INSM Position: Q3 2024 in Review

Transcend Capital Advisors sold out of Insmed (INSM) in Q3 2024, closing a stake of 4,684 shares — an estimated $314K sold.

Transcend Capital Advisors first reported a position in INSM in Q2 2024 and held it in 1 quarter. The position peaked at $314K in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Transcend Capital Advisors reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Transcend Capital Advisors sold 4,684 Insmed shares in Q3 2024, an estimated $314K.
  • Transcend Capital Advisors first reported a position in Insmed in Q2 2024 and held it in 1 quarter.
  • Transcend Capital Advisors's Insmed position peaked at $314K in Q2 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Transcend Capital Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.